Premium
Adjunctive brexpiprazole effective after inadequate antidepressant response
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30093
Subject(s) - adjunctive treatment , antidepressant , medicine , antipsychotic , depression (economics) , placebo , schizophrenia (object oriented programming) , pharmacology , psychiatry , anxiety , economics , macroeconomics , alternative medicine , pathology
The novel antipsychotic brexpiprazole improved depression symptoms compared with placebo when used as adjunctive therapy for patients who did not respond adequately to a course of antidepressant treatment, according to two studies that examined a total of three different daily doses of brexpiprazole.